SANAI HEALTH GP (01889) released its interim results, reporting a loss attributable to shareholders of 8.511 million yuan, a year-on-year decrease of 23.09%.

date
22:57 31/08/2026
avatar
GMT Eight
Sannai Health Group (01889) announced its results for the six months ending June 30, 2026. The group achieved revenue of 43.923 million yuan, a decrease of 6.99% year-on-year; the loss attributable to shareholders was 8.511 million yuan, a decrease of 23.09% year-on-year; the loss per share was 5.57 cents.
SANAI HEALTH GP (01889) announced its results for the six months ended June 30, 2026, with revenue of 43.923 million yuan, a decrease of 6.99% year-on-year; the loss attributable to shareholders amounted to 8.511 million yuan, a decrease of 23.09% year-on-year; loss per share was 5.57 cents. The announcement stated that the decrease in revenue was mainly due to the relatively low sales profit margin of pharmaceutical products sold by Fujian Ruichuang during the period.